6
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Clinical Significance of Immunologic and Immunogenetic Evaluation in Multiple Sclerosis

, &
Pages 371-379 | Published online: 07 Jul 2009

References

  • Amos D. B. Cytotoxicity Testing. Manual of Tissue Typing Techniques, U.S. Department of Health, Education and Welfare. NIH Publication. 1979; 80–545, 42–45
  • Benacerraf B., Germain R. N. The Immune Response Genes of the Major Histocompatibility Complex, Immunological Reviews. 1978; 38: 70–119
  • Bertrams H. J., Kuivert E. K. Association of Histo-compatibility Haplotype HLA-A3-B7 with Multiple Sclerosis J. Immune. 1976; 117: 1906–12
  • Davis N. C., Ho M. Manual of Clinical Immunology, American Society for Microbiology Chapter 2, N. Rose, H. Friedman, 1976; 4–16
  • Jersild C, Svejgaard A, Fog T. HLA Antigens Associated with Multiple Sclerosis, Lancet. 1972; 1: 1242–43
  • Jersild C, Fog T, Hansen S, Thomsen M, Svejgaard A, Dupont B. Histocompatibility Determinants in Multiple Sclerosis with Special Reference to Clinical Course, Lancet. 1973; 2: 1221–24
  • Kelly R. H., Scholl M. A., Harvey V. S., Devenyi A. C. Detection of Circulating Immune Complexes by Zone Electrophoresis in agarose, Clin. Chem. 1980; 26: 396–400
  • Kirby P. J., Morley J, Ponsford J. R., McDonald W. I. Defective PGE Reactivity in Leukocytes of Multiple Sclerosis Patients, Prostaglandins. 1975; 11: 621–30
  • Lehrich J. R., Arnason B. G. Histocompatibility Types and Viral Antibodies, Arch. Neurol. 1976; 33: 404–05
  • Link H. Immunoglobulins and Low Molecular Weight Proteins in Human Cerebrospinal Fluid: Chemical and Immunolgical Characterization with Special Reference to Multiple Sclerosis. Acta. Neurol. Scand. 1967; 43(Suppl 28)1–136
  • Link H, Tibbling G. Principles of Albumin and IgG Analysis in Neurological Disorders. III. Evaluation of IgG Synthesis Within the Central Nervous System in MS. Scand. J. Clin. Lab. Invest. 1977; 37: 397–401
  • Link H., Muller E., Muller R., Norby E., Olsson J. E., Stendahl G., Tibbling G. Immunoglobulin Abnormalities in Spinal Fluid in Multiple Sclerosis. Acta. Neurol. Scand., 55(Suppl. 63)
  • McAlpine D., Lumsden C. E., Acheson E. D. Course and Prognosis: Multiple Sclerosis, A Reappraisal.2nd Ed.Edinburg Chapter 7. Churchill-Livingstone 1972; 197–223
  • Olssson J. E., Link E. H., Miller R. Immunoglobulin Abnormalities in Multiple Sclerosis. Relation to Clinical Parameters: Disability, Duration and Age of Onset. J. Neurol. Sci. 1976; 27: 233–45
  • Opelz G., Terasaki P., Myers L., Ellison G., Evers G., Zabriskie J., Weiner H., Kempe H., Sibley W. The Association of HLA Antigens A3, B7 and DW2 with 330 Multiple Sclerosis Patients in the United Stated. Tissue Antigens. 1977; 9: 54–8
  • Stendahl-Brodin L.L., Ling H., Ling H, Moller E., Norrby E. Genetic Basis of Multiple Sclerosis: HLA Antigens, Disease Progression and Oligoclonal IgG in CSF. Acta. Neurol. Scand. 1979; 297–308
  • Thompson E. J. Laboratory Diagnosis of Multiple Sclerosis: Immunological and Biochemical Aspects. Brit. Med. Bull. 1977; 33: 28–33
  • Whitaker J. N., Herrmann K. L., Rogentine N, Stein S.F, Kollins L. L. Immunogenetic Analysis and Serum Viral Antibody Titers in Multiple Sclerosis. Arch. Neurol. 1976; 33: 399–40

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.